Skip to main content

Table 3 Risk factors for development of recurrence tumor after surgical resection of IPMN and MCN on the univariate and multivariate analyses (n = 245)

From: The pathological features and prognoses of intraductal papillary mucinous neoplasm and mucinous cystic neoplasm after surgical resection: a single institution series

 

Univariate analysis

Multivariate analysis

Recurrence (+) n = 37

Recurrence (−) n = 208

p value

p

Odds ratio (OR)

95% confidence interval

Age, median years (IQR)

64 (54.5–71)

63 (54–70)

0.43

   

Sex, male, % (n)

59.5 (22)

61.1 (127)

0.85

   

Diabetes mellitus, % (n)

32.4 (12)

19.7 (41)

0.08

0.32

  

Pathological diagnoses

 Malignant, % (n)

67.6 (25)

32.7 (68)

< 0.0001

< 0.0001

3.65

2.2–6.5

Tumor size, median mm (IQR)

50 (30–70)

40 (24–70)

0.49

   

Morphological type for IPMN, n = 218, recurrence (n = 34)

 Branch duct type, % (n)

17.6 (6)

15.2 (28)

0.72

   

Epithelial subtype for IPMN, n = 218, recurrence (n = 34)

 Gastric type, % (n)

32.4 (11)

43.5 (80)

0.41

   

 Intestinal type, % (n)

35.3 (12)

37.5 (69)

0.81

   

 Pancreatobiliary type, % (n)

11.8 (4)

12.0 (22)

0.98

   

 Oncocytic type, % (n)

14.7 (5)

2.2 (4)

0.01

0.031

1.69

1.13–1.97

 Mixed type, % (n)

5.9 (2)

4.9 (9)

1.0

   

Resection procedure

 TP, % (n)

5.4 (2)

6.3 (13)

1.0

   

 PD, % (n)

75.7 (28)

53.8 (112)

0.013

0.12

  

 DP, % (n)

16.2 (6)

12.5 (26)

0.54

   

 CP, % (n)

2.7 (1)

7.7 (16)

0.45

   

 Enucleation, % (n)

0 (0)

1.9 (4)

1.0

   

Peripheral invasion, % (n)

73.0 (27)

4.8 (10)

< 0.0001

< 0.0001

12.87

1.87–24.03

Margin status

 Margin with noninvasive component, % (n)

13.5 (5)

14.9 (31)

0.82

   

 Margin with invasive component, % (n)

13.5 (5)

2.4 (5)

0.02

0.039

1.99

1.08–3.06

  1. IPMN intraductal papillary mucinous neoplasm, IQR interquartile range, DP distal pancreatectomy, PD pancreaticoduodenectomy, TP total pancreatectomy, CP central pancreatectomy